Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market.
This report aims to provide a comprehensive presentation of the global market for Retinal Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Biologics. This report contains market size and forecasts of Retinal Biologics in global, including the following market information:
Global Retinal Biologics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Retinal Biologics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Macular Degeneration Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Retinal Biologics include Spark Therapeutics, Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, AbbVie Inc, Johnson & Johnson Services, Inc and Amgen Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Retinal Biologics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Biologics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Retinal Biologics Market Segment Percentages, by Type, 2022 (%)
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Global Retinal Biologics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Retinal Biologics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Retinal Biologics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Retinal Biologics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retinal Biologics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Retinal Biologics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Spark Therapeutics, Inc
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
AbbVie Inc
Johnson & Johnson Services, Inc
Amgen Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Retinal Biologics, market overview.
Chapter 2: Global Retinal Biologics market size in revenue.
Chapter 3: Detailed analysis of Retinal Biologics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Retinal Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Retinal Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Retinal Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Retinal Biologics Overall Market Size
2.1 Global Retinal Biologics Market Size: 2022 VS 2032
2.2 Global Retinal Biologics Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Retinal Biologics Players in Global Market
3.2 Top Global Retinal Biologics Companies Ranked by Revenue
3.3 Global Retinal Biologics Revenue by Companies
3.4 Top 3 and Top 5 Retinal Biologics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Retinal Biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Retinal Biologics Players in Global Market
3.6.1 List of Global Tier 1 Retinal Biologics Companies
3.6.2 List of Global Tier 2 and Tier 3 Retinal Biologics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Retinal Biologics Market Size Markets, 2022 & 2032
4.1.2 Macular Degeneration
4.1.3 Diabetic Retinopathy
4.1.4 Diabetic Macular Edema
4.1.5 Uveitis
4.1.6 Others
4.2 By Type - Global Retinal Biologics Revenue & Forecasts
4.2.1 By Type - Global Retinal Biologics Revenue, 2018-2023
4.2.2 By Type - Global Retinal Biologics Revenue, 2024-2032
4.2.3 By Type - Global Retinal Biologics Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Retinal Biologics Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Retinal Biologics Revenue & Forecasts
5.2.1 By Application - Global Retinal Biologics Revenue, 2018-2023
5.2.2 By Application - Global Retinal Biologics Revenue, 2024-2032
5.2.3 By Application - Global Retinal Biologics Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Retinal Biologics Market Size, 2022 & 2032
6.2 By Region - Global Retinal Biologics Revenue & Forecasts
6.2.1 By Region - Global Retinal Biologics Revenue, 2018-2023
6.2.2 By Region - Global Retinal Biologics Revenue, 2024-2032
6.2.3 By Region - Global Retinal Biologics Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Retinal Biologics Revenue, 2018-2032
6.3.2 US Retinal Biologics Market Size, 2018-2032
6.3.3 Canada Retinal Biologics Market Size, 2018-2032
6.3.4 Mexico Retinal Biologics Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Retinal Biologics Revenue, 2018-2032
6.4.2 Germany Retinal Biologics Market Size, 2018-2032
6.4.3 France Retinal Biologics Market Size, 2018-2032
6.4.4 U.K. Retinal Biologics Market Size, 2018-2032
6.4.5 Italy Retinal Biologics Market Size, 2018-2032
6.4.6 Russia Retinal Biologics Market Size, 2018-2032
6.4.7 Nordic Countries Retinal Biologics Market Size, 2018-2032
6.4.8 Benelux Retinal Biologics Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Retinal Biologics Revenue, 2018-2032
6.5.2 China Retinal Biologics Market Size, 2018-2032
6.5.3 Japan Retinal Biologics Market Size, 2018-2032
6.5.4 South Korea Retinal Biologics Market Size, 2018-2032
6.5.5 Southeast Asia Retinal Biologics Market Size, 2018-2032
6.5.6 India Retinal Biologics Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Retinal Biologics Revenue, 2018-2032
6.6.2 Brazil Retinal Biologics Market Size, 2018-2032
6.6.3 Argentina Retinal Biologics Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Retinal Biologics Revenue, 2018-2032
6.7.2 Turkey Retinal Biologics Market Size, 2018-2032
6.7.3 Israel Retinal Biologics Market Size, 2018-2032
6.7.4 Saudi Arabia Retinal Biologics Market Size, 2018-2032
6.7.5 UAE Retinal Biologics Market Size, 2018-2032
7 Retinal Biologics Companies Profiles
7.1 Spark Therapeutics, Inc
7.1.1 Spark Therapeutics, Inc Company Summary
7.1.2 Spark Therapeutics, Inc Business Overview
7.1.3 Spark Therapeutics, Inc Retinal Biologics Major Product Offerings
7.1.4 Spark Therapeutics, Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.1.5 Spark Therapeutics, Inc Key News & Latest Developments
7.2 F. Hoffmann-La Roche Ltd
7.2.1 F. Hoffmann-La Roche Ltd Company Summary
7.2.2 F. Hoffmann-La Roche Ltd Business Overview
7.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.3 Regeneron Pharmaceuticals, Inc
7.3.1 Regeneron Pharmaceuticals, Inc Company Summary
7.3.2 Regeneron Pharmaceuticals, Inc Business Overview
7.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Major Product Offerings
7.3.4 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.3.5 Regeneron Pharmaceuticals, Inc Key News & Latest Developments
7.4 AbbVie Inc
7.4.1 AbbVie Inc Company Summary
7.4.2 AbbVie Inc Business Overview
7.4.3 AbbVie Inc Retinal Biologics Major Product Offerings
7.4.4 AbbVie Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.4.5 AbbVie Inc Key News & Latest Developments
7.5 Johnson & Johnson Services, Inc
7.5.1 Johnson & Johnson Services, Inc Company Summary
7.5.2 Johnson & Johnson Services, Inc Business Overview
7.5.3 Johnson & Johnson Services, Inc Retinal Biologics Major Product Offerings
7.5.4 Johnson & Johnson Services, Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Services, Inc Key News & Latest Developments
7.6 Amgen Inc
7.6.1 Amgen Inc Company Summary
7.6.2 Amgen Inc Business Overview
7.6.3 Amgen Inc Retinal Biologics Major Product Offerings
7.6.4 Amgen Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.6.5 Amgen Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Retinal Biologics Market Opportunities & Trends in Global Market
Table 2. Retinal Biologics Market Drivers in Global Market
Table 3. Retinal Biologics Market Restraints in Global Market
Table 4. Key Players of Retinal Biologics in Global Market
Table 5. Top Retinal Biologics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Retinal Biologics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Retinal Biologics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Retinal Biologics Product Type
Table 9. List of Global Tier 1 Retinal Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retinal Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Retinal Biologics Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Retinal Biologics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Retinal Biologics Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Retinal Biologics Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Retinal Biologics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Retinal Biologics Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Retinal Biologics Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Retinal Biologics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Retinal Biologics Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Retinal Biologics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Retinal Biologics Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Retinal Biologics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Retinal Biologics Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Retinal Biologics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Retinal Biologics Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Retinal Biologics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Retinal Biologics Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Retinal Biologics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Retinal Biologics Revenue, (US$, Mn), 2024-2032
Table 30. Spark Therapeutics, Inc Company Summary
Table 31. Spark Therapeutics, Inc Retinal Biologics Product Offerings
Table 32. Spark Therapeutics, Inc Retinal Biologics Revenue (US$, Mn) & (2018-2023)
Table 33. Spark Therapeutics, Inc Key News & Latest Developments
Table 34. F. Hoffmann-La Roche Ltd Company Summary
Table 35. F. Hoffmann-La Roche Ltd Retinal Biologics Product Offerings
Table 36. F. Hoffmann-La Roche Ltd Retinal Biologics Revenue (US$, Mn) & (2018-2023)
Table 37. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 38. Regeneron Pharmaceuticals, Inc Company Summary
Table 39. Regeneron Pharmaceuticals, Inc Retinal Biologics Product Offerings
Table 40. Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue (US$, Mn) & (2018-2023)
Table 41. Regeneron Pharmaceuticals, Inc Key News & Latest Developments
Table 42. AbbVie Inc Company Summary
Table 43. AbbVie Inc Retinal Biologics Product Offerings
Table 44. AbbVie Inc Retinal Biologics Revenue (US$, Mn) & (2018-2023)
Table 45. AbbVie Inc Key News & Latest Developments
Table 46. Johnson & Johnson Services, Inc Company Summary
Table 47. Johnson & Johnson Services, Inc Retinal Biologics Product Offerings
Table 48. Johnson & Johnson Services, Inc Retinal Biologics Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Services, Inc Key News & Latest Developments
Table 50. Amgen Inc Company Summary
Table 51. Amgen Inc Retinal Biologics Product Offerings
Table 52. Amgen Inc Retinal Biologics Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Inc Key News & Latest Developments
List of Figures
Figure 1. Retinal Biologics Segment by Type in 2022
Figure 2. Retinal Biologics Segment by Application in 2022
Figure 3. Global Retinal Biologics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Retinal Biologics Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Retinal Biologics Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Retinal Biologics Revenue in 2022
Figure 8. By Type - Global Retinal Biologics Revenue Market Share, 2018-2032
Figure 9. By Application - Global Retinal Biologics Revenue Market Share, 2018-2032
Figure 10. By Type - Global Retinal Biologics Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Retinal Biologics Revenue Market Share, 2018-2032
Figure 12. By Application - Global Retinal Biologics Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Retinal Biologics Revenue Market Share, 2018-2032
Figure 14. By Region - Global Retinal Biologics Revenue Market Share, 2018-2032
Figure 15. By Country - North America Retinal Biologics Revenue Market Share, 2018-2032
Figure 16. US Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Retinal Biologics Revenue Market Share, 2018-2032
Figure 20. Germany Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 21. France Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Retinal Biologics Revenue Market Share, 2018-2032
Figure 28. China Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 32. India Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Retinal Biologics Revenue Market Share, 2018-2032
Figure 34. Brazil Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Retinal Biologics Revenue Market Share, 2018-2032
Figure 37. Turkey Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Retinal Biologics Revenue, (US$, Mn), 2018-2032
Figure 41. Spark Therapeutics, Inc Retinal Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. F. Hoffmann-La Roche Ltd Retinal Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AbbVie Inc Retinal Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Services, Inc Retinal Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Inc Retinal Biologics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
